News
By Renee Rowe
|
February 21, 2002
While adult stem cells hold some potential for use in the development of new therapies, these possible benefits pale in comparison to the enormous potential of embryonic stem cells.
The federal government should give the green light to scientists who want to continue stem cell research.
Adult stem cells regulate other cells in the body and replace them when they die from injury, disease or old age.
On the other hand, embryonic stem cells are "blank" cells that have the ability to divide indefinitely in culture and develop into specialized cells.
President Bush and Congress should take this information into account during their ongoing discussions of stem cell research.
Bush has rejected the possibilities of stem cell research because he let his religious beliefs take precedence over the benefits of scientific research.
"The Bush administration has been incoherent," said Paul Lombardo, member of the core faculty at the University Center of Biomedical Ethics.
"The stem cell avenue is being cut off before knowing whether or not it will prove useful," Lombardo added.
The National Academy of Sciences, an independent research institution that often advises policymakers, disagrees with Bush on the cloning issue.
The academy strongly endorses stem cell research, which holds great promise for developing new therapies that could cure a wide range of human diseases.
The academy is correct in taking a position against the Bush administration because scientific research could make new opportunities available to people suffering from incurable maladies.
"It is important to continue with embryonic research because it will ultimately yield information that can be applied to adult stem cells to treat and manipulate therapies," Plastic Surgery Prof.